Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.28 HKD | +4.79% | +13.10% | -10.14% |
25/04 | Abbisko Cayman's Liver Cancer Drug Gets US FDA Orphan Drug Designation | MT |
24/04 | Abbisko Cayman Limited Announces Resignation of Tian Huimin as Joint Company Secretary | CI |
Sales 2024 * | 168M 23.19M 182M 1.93B | Sales 2025 * | 255M 35.16M 275M 2.93B | Capitalization | 1.77B 245M 1.92B 20.4B |
---|---|---|---|---|---|
Net income 2024 * | -517M -71.35M -559M -5.95B | Net income 2025 * | -785M -108M -848M -9.03B | EV / Sales 2024 * | -0.92 x |
Net cash position 2024 * | 1.93B 266M 2.08B 22.19B | Net cash position 2025 * | 1.39B 191M 1.5B 15.94B | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-3.7
x | P/E ratio 2025 * |
-3.23
x | Employees | 258 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.44% |
1 day | +4.79% | ||
1 week | +13.10% | ||
Current month | +13.89% | ||
1 month | +14.69% | ||
3 months | +28.63% | ||
6 months | +26.15% | ||
Current year | -10.14% |
Managers | Title | Age | Since |
---|---|---|---|
Zhui Chen
FOU | Founder | 49 | 12/16/12 |
Yao Chang Xu
CEO | Chief Executive Officer | 67 | 12/16/12 |
Hong Ping Yu
FOU | Founder | 56 | 12/16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Bin Sun
BRD | Director/Board Member | 48 | 30/21/30 |
Piao Yang Sun
BRD | Director/Board Member | 65 | 30/21/30 |
Hong Ping Yu
FOU | Founder | 56 | 12/16/12 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.28 | +4.79% | 1,534,000 |
25/24/25 | 3.13 | +0.64% | 670,000 |
24/24/24 | 3.11 | +1.97% | 902,000 |
23/24/23 | 3.05 | +1.33% | 1,283,607 |
22/24/22 | 3.01 | +3.79% | 1,626,000 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 01:38 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.14% | 245M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 2256 Stock